NasdaqCM - Nasdaq Real Time Price USD
Genelux Corporation (GNLX)
2.9600
+0.1100
+(3.86%)
At close: May 9 at 4:00:01 PM EDT
2.9600
0.00
(0.00%)
After hours: May 9 at 4:05:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.21 | -0.22 | -0.89 | -0.96 |
| Low Estimate | -0.22 | -0.25 | -0.96 | -1.02 |
| High Estimate | -0.21 | -0.2 | -0.83 | -0.9 |
| Year Ago EPS | -0.22 | -0.19 | -0.95 | -0.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 4 |
| Avg. Estimate | -- | -- | -- | 3.31M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 13.25M |
| Year Ago Sales | -- | -- | 8k | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.19 | -0.18 | -0.24 |
| EPS Actual | -0.22 | -0.19 | -0.26 | -0.21 |
| Difference | -0.01 | 0 | -0.08 | 0.03 |
| Surprise % | -6.02% | 0.00% | -42.47% | 13.40% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.22 | -0.89 | -0.96 |
| 7 Days Ago | -0.26 | -0.25 | -1.02 | -1.07 |
| 30 Days Ago | -0.28 | -0.27 | -1.08 | -1.13 |
| 60 Days Ago | -0.36 | -0.26 | -1.18 | -1.37 |
| 90 Days Ago | -0.36 | -0.26 | -1.18 | -1.37 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 2 | -- | 1 | 2 |
| Down Last 7 Days | -- | 3 | -- | 1 |
| Down Last 30 Days | 1 | 2 | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GNLX | 3.41% | -14.47% | 6.58% | -8.54% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | Benchmark: Speculative Buy to Speculative Buy | 5/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/25/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Initiated | Guggenheim: Buy | 10/29/2024 |
| Initiated | Roth MKM: Buy | 8/27/2024 |
Related Tickers
SABS SAB Biotherapeutics, Inc.
1.7900
+3.47%
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
ERAS Erasca, Inc.
1.3900
0.00%
ALLR Allarity Therapeutics, Inc.
1.0500
-1.87%
GLUE Monte Rosa Therapeutics, Inc.
4.0900
-3.08%
REPL Replimune Group, Inc.
7.71
-0.77%
BCDA BioCardia, Inc.
2.8500
0.00%
FHTX Foghorn Therapeutics Inc.
4.2000
-7.28%
MGTX MeiraGTx Holdings plc
5.42
-0.91%
ADAG Adagene Inc.
1.6000
+0.63%